Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal inflammatory drug

Current Medicinal Chemistry

Volumn 15, Issue 3, 2008, Pages 278-283

  Suleyman, H ^a   Cadirci, E ^a   Albayrak, A ^a   Halici, Z ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Antiulcer effect; Chemical structure; Cyclooxygenase; Nimesulide; NSAID; Side effect

Indexed keywords

ACECLOFENAC; ACETYLSALICYLIC ACID; ADRENALIN; CALCIUM CHANNEL; CARBIDOPA; CELECOXIB; CETIRIZINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FLOSULIDE; FLUFENAMIC ACID; FLURBIPROFEN; INDOMETACIN; KETOPROFEN; MECLOFENAMIC ACID; MEFENAMIC ACID; MELOXICAM; METIROSINE; METYRAPONE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PIROXICAM; PREDNISOLONE; PROSTAGLANDIN E2; RANITIDINE; ROFECOXIB; UNINDEXED DRUG;

ALLERGIC RHINITIS; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPYRETIC ACTIVITY; CANCER INHIBITION; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CHOLESTASIS; DRUG MEGADOSE; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATORY DISEASE; LIVER INJURY; LIVER NECROSIS; MONOTHERAPY; NONHUMAN; PAIN; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS INHIBITION; RESPIRATORY TRACT INFECTION; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; STOMACH INJURY; STOMACH PROTECTION; STOMACH ULCER; STRUCTURE ACTIVITY RELATION; ULCER; ULCER PERFORATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; HUMANS; STOMACH ULCER; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 39349118197     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986708783497247     Document Type: Review

References (77)

1. Suleyman, H.; Demircan, B.; Karagoz, Y. Pharmacol. Rep., 2007, 59, 257-268.
2. Mitchell, J.A.; Warner, T.D. Br. J. Pharmacol., 1999, 128, 1121-32.
3. Wallace, J.L. Gastroenterology, 1997, 112, 1000-1016.
4. Burke, A.; Smyth, E.; Fitz Gerald, G.A. In Goodman and Gilman's the pharmacologycal basis of therapeutics; Laurence L. Brunton, Ed.; Mc Graw-Hill: New-york, 2006, pp. 671-717.
5. Laine, L. J. Pain Symptom Manage, 2003, 25, 32-40.
6. DeMaria, A.N.; Weir, M.R. J. Pain Symptom Manage, 2003, 25, 41-49.
7. Demircan, B.; Celik, G.; Suleyman, H.; Akcay, F. Pain Clin., 2005, 17, 383-388.
8. Suleyman, H.; Demirezer, L.Ó.; Kuruuzum-Uz, A.; Akcay, F. Pharmazie, 2002, 57, 204-205.
9. Thawani, V.; Sontakke, S.; Gharpure, K.; Pimpalkhute, S. Indian J. Pharmacol., 2003, 35, 121-122.
10. Cullen, L.; Kelly, L.; Connor, S.O.; Fitzgerald, D.J. J. Pharmacol. Exp. Ther., 1998, 287, 578-582.
11. Nakatsugi, S.; Terada, N.; Yoshimura, T.; Horie, Y.; Furukawa, M. Prostaglandins Leukot. Essent. Fatty Acids. 1996, 55, 395-402.
12. Kayaalp, S.O. Medical pharmacology, in terms of rational treatment (Rasyonel tedavi yonunden tibbi farmakoloji); Hacettepe-Taş Kitapçιlιk Ltd.Şti.: Ankara, 2000.
13. Ferreira, S.H. Int. J. Clin. Pract. Suppl., 2002, 128, 2-10.
14. Werner, M.F.; Souza, G.E.; Zampronio, A.R. Eur. J. Pharmacol., 2006, 543, 181-189.
15. Chandra, J.; Bhatnagar, S.K. Indian J. Pediatr., 2002, 69, 69-74.
16. Tool, A.T.; Verhoeven, A.J. Arzneimittelforschung. 1995, 45, 1110-4.
17. Verhoeven, A.J.; Tool, A.T.; Kuijpers, T.W.; Roos, D. Drugs, 1993, 46, 52-58.
18. Gómez-Gaviro, M.V.; González-Alvaro, I.; Domínguez-Jiménez, C.; Peschon, J.; Black, R.A.; Sánchez-Madrid, F.; Díaz-González, F. J. Biol. Chem., 2002, 277, 38212-21.
19. Famaey, J.P. Inflamm. Res., 1997, 46, 437-46.
20. Wallace, J.L.; Chapman, K.; McKnight, W.B. Br. J. Pharmacol., 1999, 126, 1200-1204.
21. Suleyman, H.; Gul, H.I.; Asoglu, M. Pharmacol. Res., 2003, 47, 471-475.
22. Kotsinas, A.; Gorgoulis, V.; Zacharatos, P.; Zioris, H.; Triposkiadis, F.; Donta, I.; Kyriakidis, M.; Karayannacos, P.; Kittas, C. Biochem. Biophys. Res. Commun., 1999, 254, 651-656.
23. Akgun, H.; Balkan, A.; Bilgin, A.A.; Calis, U.; Gokhan, N.; Dalkara, S.; Erdogan, H.; Erol, D.D.; Ertan, M.; Ozkanli, F.; Palaska, E.; Sarac, S.; Safak, C.; Tozkoparan, B. Pharmaceutical Chemistry (Farmasotik Kimya); Hacettepe Universitesty: Ankara, 2004.
24. Michaux, C.; Charlier, C. Mini Rev. Med. Chem., 2004, 6, 603-15.
25. Futaki, N.; Yoshikawa, K.; Hamasaka, Y.; Arai, I.; Higuchi, S.; Iizuka, H.; Otomo, S. Gen. Pharmacol., 1993, 24, 105-10.
26. Klein, T.; Nusing, R.M.; Pfeilschifter, J.; Ullrich, V. Biochem. Pharmacol., 1994, 48, 1605-10.
27. Tavares, I.A.; Bishai, P.M.; Bennett, A. Arzneimittelforschung, 1995, 45, 1093-5.
28. Teixeira, L. H. P.; Fraga, C.A.M.; Barreiro, E.J. J. Braz. Chem. Soc., 1998, 9, 119-130.
29. Fabiola, G.F.; Pattabhi, V.; Nagarajan, K. Bioorg. Med. Chem., 1998, 6, 2337-44.
30. Bezerra-Netto, H.J.; Lacerda, D.I.; Miranda, A.L.; Alves, H.M.; Barreiro, E.J.; Fraga, C.A. Bioorg. Med. Chem., 2006, 14, 7924-35.
31. Black, W. C.; Bayly, C.; Belley, M.; Chan, C.C.; Charleson, S.; Denis, D.; Gauthier, J.Y.; Gordon, K.; Guay, D.; Kargman, S.; Lau, C.K.; Leblanc, Y.; Mancini, J.; Ouellet, M.; Percival, D.; Roy, P.; Skorey, K.; Tagari, P.; Vickers, P.; Wong, E.; Xu L.; Prasit, P. Bioorg. Med. Chem. Lett., 1996, 6, 725-730
32. Kalgutkar, A.S.; Crews, B.C.; Rowlinson, S.W.; Marnett, A.B.; Kozak, K.R., Remmel, R.P.; Marnett, L.J. Proc. Natl. Acad. Sci. USA, 2000, 97, 925-30.
33. Sawdy, R.; Slater, D.; Jones, G.; Poston, L.; Bennett, P.R. J. Soc. Gynecol. Investig., 1997, 4, 337.
34. Knock, G.A.; Aaronson, P.I. Br. J. Pharmacol., 1999, 127, 1470-1478.
35. Pulkkinen, M. Drugs, 1993, 46, 129-133.
36. Rewari, S.; Gupta, U. J. Assoc. Physicians India, 1999, 47, 389-392.
37. Hida, T.; Kozaki, K.; Muramatsu, H.; Masuda, A.; Shimizu, S.; Mitsudomi, T.; Sugiura, T.; Ogawa, M.; Takahashi, T. Clin. Cancer Res., 2000, 6, 2006-2011.
38. Fukutake, M.; Nakatsugi, S.; Isoi, T.; Takahashi, M.; Ohta, T.; Mamiya, S.; Taniguchi, Y.; Sato, H.; Fukuda, K.; Sugimura, T.; Wakabayashi, K. Carcinogenesis, 1998, 19, 1939-1942.
39. Okajima, E.; Denda, A.; Ozono, S.; Takahama, M.; Akai, H.; Sasaki, Y.; Kitayama, W.; Wakabayashi, K.; Konishi, Y. Cancer Res., 1998, 58, 3028-3031.
40. Nakatsugi, S.; Ohta, T.; Kawamori, T.; Mutoh, M.; Tanigawa, T.; Watanabe, K.; Sugie, S.; Sugimura, T.; Wakabayashi, K. Jpn. J. Cancer Res., 2000, 91, 886-892.
41. Shiotani, H.; Denda, A.; Yamamoto, K.; Kitayama, W.; Endoh, T.; Sasaki, Y.; Tsutsumi, M.; Sugimura, M.; Konishi, Y. Cancer Res., 2001, 61, 1451-1456.
42. Denda, A.; Kitayama, W.; Murata, A.; Kishida, H.; Sasaki, Y.; Kusuoka, O.; Tsujiuchi, T.; Tsutusumi, M.; Nakae, D.; Takagi, H.; Konishi, Y. Carcinogenesis, 2002, 23, 245-56.
43. Eibl, G.; Reber, H.A.; Wente, M.N.; Hines, O.J. Pancreas, 2003, 26, 33-41.
44. Azab, A.N.; Kobal, S.; Rubin, M.; Kaplanski, J. Cardiology, 2005, 10, 92-100.
45. Dapino, P.; Ottonello, L.; Dallegri, F. Respiration, 1994, 61, 336-341.
46. Bevilacqua, M.; Vago, T.; Baldi, G.; Renesto, E.; Dallegri, F.; Norbiato, G. Eur. J. Pharmacol., 1994, 268, 415-423.
47. Verhoeven, A.J.; Tool, A.T.; Kuijpers, T.W.; Roos, D. Drugs, 1993, 46, 52-58.
48. Ferraire, S.H. Drugs, 1993, 46, 1-9.
49. Altinkaynak, K.; Süleyman, H.; Akçay, F. Pol. J. Pharmacol., 2003, 55, 646-648.
50. Le Filliatre, G.; Sayah, S.; Latoumerie, V.; Renaud, J.F.; Finet, M.; Hanf, R. Br. J. Pharmacol., 2001, 132, 1581-1589.
51. Kullich, W.C.; Niksic, F.; Klein, G. Int. J. Clin. Pract. Suppl., 2002, 128, 24-29.
52. Van Antwerpen, P.; Dubois, J.; Gelbcke, M.; Neve, J. Free Radic. Res., 2004, 38, 251-258.
53. Suleyman, H.; Akçay, F.; Altinkaynak, K. Pharmacol. Res., 2002, 45, 155-158.
54. Suleyman, H.; Altinkaynak, K.; Gocer, F.; Maras, A.; Akcay, F.; Onuk, M.D.; Gepdiremen, A. Pol. J. Pharmacol., 2002, 54, 255-259.
55. Suleyman, H.; Demircan, B.; Gocer, F.; Halici, Z.; Hacimuftuoglu, A. Pol. J. Pharmacol., 2004, 56, 799-804.
56. Suleyman, H.; Halici, Z.; Cadirci, E.; Hacimuftuoglu, A.; Keles, S.; Gocer, F. Naunyn Schmiedebergs Arch. Pharmacol., 2007, 375, 189-198.
57. Takeuchi, K.; Nishiwaki, H.; Okada, M.; Niida, H.; Okabe, S. Gastroenterology, 1989, 97, 284-293.
58. Filaretova, L.; Tanaka, A.; Komoike, Y.; Takeuchi, K. Inflammopharmacology, 2002, 10, 413-422.
59. Reams, G.; Bauer, J.H. In Atlas of diseases of the kidney; Christopher S. Wilcox, Ed.; Blackwell science: Philadelphia, 1999, pp. 28-30.
60. Suleyman, H.; Salamci, E.; Cadirci, E.; Halici, Z. Med. Chem. Res. DOI number: 10.1007/s00044-007-9009-8
61. Valero Santiago, A.; Gonzalez-Morales, E.; Martí Guadaño E.; GETNIA. Allergy, 2003, 58, 367-369.
62. Andri, L.; Senna, G.; Betteli, C.; Givanni, S.; Scaricabarozzi, I.; Mezzelani, P.; Andri, G. Ann. Allergy, 1994, 72, 29-32.
63. Bianco, S.; Robuschi, M.; Petrigni, G.; Scuri, M.; Pieroni, M.G., Refini, R.M.; Vaghi, A.; Sestini, P.S. Drugs, 1993, 46, 115-120.
64. Davis, R.; Brogden, R.N. Drugs, 1994, 48, 431-454.
65. Spiegel, B.M.; Chiou, C.F.; Ofman, J. J. Arthritis Rheum., 2005, 53, 185-197.
66. Costagliola, C.; Parmeggiani, F.; Caccavale, A.; Sebastiani, A. Am. J. Ophthalmol., 2006, 141, 379-381.
67. Grimes, K.R.; Warren, G.W.; Fang, F.; Xu, Y.; St Clair, W.H. acol. Rep., 2006, 16, 771-776.
68. Buttgereit, F.; Burmester, G.R.; Simon, L.S. Am. J. Med., 2001, 110, 13-19.
69. White, W.B.; Faich, G.; Whelton, A.; Maurath, C.; Ridge, N.J.; Verburg, K.M., Geis, G.S.; Lefkowit, J.B. Am. J. Cardiol. 15, 2002, 89, 425-430.
70. Rainsford, K.D. Inflammopharmacology, 2006, 14, 120-137.
71. Kaushal, N.; Sanyal, S.N. Mol. Cell Biochem., 2007, 294, 107-115.
72. Andrade, R.J.; Lucena, M.I.; Fernandez, M.C.; Gonzalez, M. J. Hepatol., 2000, 32, 174.
73. Merlani, G.; Fox, M.; Ochen, H.P.; Cathomas, G.; Renner, E.L.; Fattinger, K.; Schneemann, M.; Kullak-Ublick, G.A. Eur. J. Clin. Pharmacol., 2001, 57, 321-326.
74. Moreno, A.J.; Oliveira, P.J.; Nova, C.D.; Alvaro, A.R.; Moreira, R.A.; Santos, S.M.; Macedo, T. J. Biochem. Mol. Toxicol., 2007, 21, 53-61.
75. Diao; H.L.; Zhu, H.; Ma, H.; Tan, H.N.; Cong, J.; Su, R.W.; Yang, Z.M. Front. Biosci., 2007, 12, 3333-3342.
76. Teixeira, M.; Silva, E.; Selores, M. Dermatol. Aline J., 2006, 12, 20.
77. Suleyman, H.; Demirezer, L.O.; Kuruuzum-Uz, A. Pharmazie., 2004, 59, 147-149.